Last reviewed · How we verify
Peripheral venous insufficiency
Approved treatments
- MONOXERUTIN
Monoxerutin works by improving blood vessel function and reducing inflammation.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Peripheral venous insufficiency patent landscape — cliff calendar, originator estates, attackable patents
- Peripheral venous insufficiency treatment landscape brief
- Peripheral venous insufficiency treatment updates RSS
Frequently asked questions about Peripheral venous insufficiency
What drugs treat Peripheral venous insufficiency?
Tracked treatments include MONOXERUTIN.
What is the treatment for Peripheral venous insufficiency?
Standard treatment for Peripheral venous insufficiency includes MONOXERUTIN. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Peripheral venous insufficiency patent cliff · Peripheral venous insufficiency CI report
- Treatment: MONOXERUTIN
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing